TL1 Trainee Moses Chung shared the potential to conduct more accurate risk assessments and scalable decision support through a prognosis model examining the patient history of people with oropharyngeal squamous cell carcinoma (OPSCC).
TL1 Trainee Moses Chung Develops Approach to Improve the Prediction of Oropharyngeal Cancer Outcomes
View Content